XML 47 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Parent Company Financial Information
12 Months Ended
Dec. 31, 2017
Parent Company Financial Information [Abstract]  
Parent Company Financial Information
22.
Parent Company Financial Information

 
Condensed Balance Sheets
 
 
December 31,
 
(In thousands)
 
2017
  
2016
 
Assets
      
Cash and cash equivalents
 
$
7,572
  
$
4,152
 
AFS securities, at estimated fair value
  
10,065
   
15,273
 
Trading securities
  
11,245
   
8,968
 
Investment in subsidiaries, on equity basis
  
1,048,908
   
1,006,444
 
Other assets
  
40,461
   
44,178
 
Total assets
 
$
1,118,251
  
$
1,079,015
 
Liabilities and Stockholders’ Equity
        
Total liabilities
 
$
160,074
  
$
165,699
 
Stockholders’ equity
  
958,177
   
913,316
 
Total liabilities and stockholders’ equity
 
$
1,118,251
  
$
1,079,015
 

Condensed Statements of Income
 
 
Years ended December 31,
 
(In thousands)
 
2017
  
2016
  
2015
 
Dividends from subsidiaries
 
$
38,300
  
$
10,200
  
$
78,200
 
Management fee from subsidiaries
  
99,319
   
95,244
   
92,629
 
Net securities gains
  
2,237
   
652
   
3,034
 
Interest, dividends and other income
  
928
   
976
   
693
 
Total revenue
 $
140,784
  $
107,072
  $
174,556
 
Operating expenses
  
100,667
   
97,977
   
94,332
 
Income before income tax benefit and equity in undistributed income of subsidiaries
  
40,117
   
9,095
   
80,224
 
Income tax expense (benefit)
  
2,233
 
  
(321
  
515
 
Dividends in excess of income (equity in undistributed income) of subsidiaries
  
44,267
   
68,993
   
(3,284
)
Net income
 
$
82,151
  
$
78,409
  
$
76,425
 

Condensed Statements of Cash Flow
 
 
Years ended December 31,
 
(In thousands)
 
2017
  
2016
  
2015
 
Operating activities
         
Net income
 
$
82,151
  
$
78,409
  
$
76,425
 
Adjustments to reconcile net income to net cash provided by operating activities
            
Depreciation and amortization of premises and equipment
  
2,974
   
2,805
   
2,522
 
Excess tax benefit on stock-based compensation
  
1,769
   
1,055
   
(43
Stock-based compensation expense
  
3,644
   
4,378
   
4,086
 
Net (gain) on sales of AFS securities
  
(2,238
)
  
(652
)
  
(3,034
)
Re-evaluation of deferred tax amounts from Tax Act
  
3,339
   
-
   
-
 
Equity in undistributed income of subsidiaries
  
(82,567
)
  
(79,193
)
  
(74,916
)
Cash dividend from subsidiaries
  
38,300
   
10,200
   
78,200
 
Bank owned life insurance income
  
(328
)
  
(356
)
  
(292
)
Net change in other liabilities
  
(5,624
)
  
(8,596
)
  
6,770
 
Net change in other assets
  
(368
)
  
22,728
   
(6,652
)
Net cash provided by operating activities
 $
41,052
  $
30,778
  $
83,066
 
Investing activities
            
Proceeds on sales and maturities of AFS securities
 $
4,710
  $
1,783
  $
5,297
 
Purchases of AFS securities
  
(9
)
  
(580
)
  
(3,083
)
Proceeds from settlement of bank owned life insurance
  
308
   
-
   
-
 
Net purchases of premises and equipment
  
(2,264
)
  
(3,083
)
  
(2,930
)
Net cash provided by (used in) investing activities
 $
2,745
  $
(1,880
)
 $
(716
)
Financing activities
            
Proceeds from the issuance of shares to employee benefit plans and other stock plans
 $
3,309
  $
6,032
  $
8,856
 
Cash paid by employer for tax-withholding on stock issuance
  
(3,582
)
  
(3,387
)
  
(1,164
)
Purchases of treasury shares
  
-
   
(17,193
)
  
(26,797
)
Cash dividends and payments for fractional shares
  
(40,104
)
  
(38,880
)
  
(38,149
)
Net cash (used in) financing activities
 $
(40,377
)
 $
(53,428
)
 $
(57,254
)
Net increase (decrease) in cash and cash equivalents
 $
3,420
  $
(24,530
)
 $
25,096
 
Cash and cash equivalents at beginning of year
  
4,152
   
28,682
   
3,586
 
Cash and cash equivalents at end of year
 
$
7,572
  
$
4,152
  
$
28,682
 

A statement of changes in stockholders’ equity has not been presented since it is the same as the consolidated statement of changes in stockholders’ equity previously presented.